Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2001-03-29
2009-02-24
Morris, Patricia L (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S270400
Reexamination Certificate
active
07495018
ABSTRACT:
(1) A 1,3-thiazole compound of which the 5-position is substituted with a 4-pyridyl group having a substituent including no aromatic group or (2) a 1,3-thiazole compound of which the 5-position is substituted with a pyridyl group having at the position adjacent to a nitrogen atom of the pyridyl group a substituent including no aromatic group has an excellent p38 MAP kinase inhibitory activity.
REFERENCES:
patent: 4612321 (1986-09-01), Shinji et al.
patent: 0 117 082 (1984-08-01), None
patent: 0 199 968 (1986-11-01), None
patent: 0 199 968 (1986-12-01), None
patent: 0 223 178 (1987-05-01), None
patent: 0 280 873 (1988-09-01), None
patent: 61-225182 (1986-10-01), None
patent: 5-70446 (1993-03-01), None
patent: 11-49762 (1999-02-01), None
patent: 93 14081 (1993-07-01), None
patent: 93 15071 (1993-08-01), None
patent: 95 13067 (1995-05-01), None
patent: 97/12876 (1997-04-01), None
patent: 99 21555 (1999-05-01), None
patent: 99 64418 (1999-12-01), None
patent: 00/64894 (2000-11-01), None
patent: 01 10865 (2001-02-01), None
Wagner et al., “Identification of, etc.,” J. Org. Chem., 2003, 68, 4527-4530.
Odeh, “Short Analytical Review, etc., ”Clinical Immunology and Immunopathology, 83(2), 103-116, 1997.
Campbell et al., “Molecular targets, etc.,” Immunology and Cell Biology (2003) 81, 354-366.
Bondenson, “Review the Mechanisms, etc.,” Gen. Pharmaco., 29(2), 127-150, 1997.
Database WPI, Section Ch, Week 199918, Derwent Publications Ltd., London, GB; AN 1999-210823 XP002177994 & JP 11 049762 A (Japan Tobacco Inc.), Feb. 23, 1999.
Patent Abstracts of Japan, vol. 017, No. 391, Jul. 22, 1993 & JP 05 070446, Mar. 23, 1993.
Database WPI, Section Ch, Week 198646, Derwent Publications Ltd., London, GB; AN 1986-302686 XP002178137 & JP 61 225182 A (Zenyaku Kogyo K.K.), Oct. 6, 1986.
Kimura Hiroyuki
Miwatashi Seiji
Naruo Ken-ichi
Ohkawa Shigenori
Morris Patricia L
Takeda Pharmaceutical Company Limited
Wenderoth , Lind & Ponack, L.L.P.
LandOfFree
Substituted 1,3-thiazole compounds, their production and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1,3-thiazole compounds, their production and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1,3-thiazole compounds, their production and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4053288